APTO logo

Aptose Biosciences (APTO) Retained Earnings

Annual Retained Earnings

-$515.54 M
-$51.21 M-11.03%

31 December 2023

APTO Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$539.38 M
-$6.95 M-1.31%

30 September 2024

APTO Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APTO Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.0%-7.1%
3 y3 years-44.4%-35.5%
5 y5 years-87.0%-83.3%

APTO Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-44.4%at low-35.5%at low
5 y5 years-87.0%at low-83.3%at low
alltimeall time-2419.6%at low-2465.8%at low

Aptose Biosciences Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$539.38 M(+1.3%)
June 2024
-
-$532.43 M(+1.4%)
Mar 2024
-
-$525.18 M(+1.9%)
Dec 2023
-$515.54 M(+11.0%)
-$515.54 M(+2.4%)
Sept 2023
-
-$503.58 M(+2.3%)
June 2023
-
-$492.13 M(+3.0%)
Mar 2023
-
-$478.01 M(+2.9%)
Dec 2022
-$464.33 M(+9.9%)
-$464.33 M(+2.2%)
Sept 2022
-
-$454.33 M(+2.2%)
June 2022
-
-$444.55 M(+2.4%)
Mar 2022
-
-$433.99 M(+2.7%)
Dec 2021
-$422.51 M(+18.3%)
-$422.51 M(+6.1%)
Sept 2021
-
-$398.18 M(+2.9%)
June 2021
-
-$386.85 M(+3.6%)
Mar 2021
-
-$373.38 M(+4.5%)
Dec 2020
-$357.15 M(+18.3%)
-$357.15 M(+4.3%)
Sept 2020
-
-$342.44 M(+4.0%)
June 2020
-
-$329.19 M(+5.0%)
Mar 2020
-
-$313.44 M(+3.8%)
Dec 2019
-$301.92 M(+9.5%)
-$301.92 M(+2.6%)
Sept 2019
-
-$294.21 M(+2.4%)
June 2019
-
-$287.36 M(+2.2%)
Mar 2019
-
-$281.14 M(+2.0%)
Dec 2018
-$275.64 M(+11.7%)
-$275.64 M(+2.3%)
Sept 2018
-
-$269.39 M(+2.1%)
June 2018
-
-$263.87 M(+4.0%)
Mar 2018
-
-$253.60 M(+2.8%)
Dec 2017
-$246.77 M(+5.0%)
-$246.77 M(+16.6%)
Sept 2017
-
-$211.56 M(+6.2%)
June 2017
-
-$199.25 M(+3.8%)
Mar 2017
-
-$191.88 M(-18.4%)
Dec 2016
-$235.13 M(+6.4%)
-$235.13 M(+24.8%)
Sept 2016
-
-$188.33 M(+0.0%)
June 2016
-
-$188.28 M(+2.7%)
Mar 2016
-
-$183.34 M(-17.0%)
Dec 2015
-$220.89 M(+17.5%)
-$220.89 M(+29.8%)
Sept 2015
-
-$170.19 M(-6.2%)
June 2015
-
-$181.43 M(+3.7%)
Mar 2015
-
-$174.99 M(-9.0%)
Dec 2014
-$188.04 M(-3.1%)
-
Sept 2014
-
-$192.35 M(-0.9%)
May 2014
-$194.01 M(-0.0%)
-$194.01 M(+4.6%)
Feb 2014
-
-$185.40 M(-3.4%)
Nov 2013
-
-$192.01 M(+0.7%)
Aug 2013
-
-$190.72 M(-1.7%)
May 2013
-$194.01 M(+2.8%)
-$194.01 M(-0.0%)
Feb 2013
-
-$194.03 M(-2.3%)
Nov 2012
-
-$198.59 M(+0.8%)
Aug 2012
-
-$197.03 M(+4.4%)
May 2012
-$188.64 M(-2.9%)
-$188.64 M(-3.0%)
Feb 2012
-
-$194.50 M(+4.4%)
Nov 2011
-
-$186.29 M(-4.5%)
Aug 2011
-
-$195.00 M(+0.4%)
May 2011
-$194.28 M
-$194.28 M(+1.0%)
Feb 2011
-
-$192.31 M(+5.1%)
DateAnnualQuarterly
Nov 2010
-
-$182.93 M(+4.7%)
Aug 2010
-
-$174.69 M(+0.1%)
May 2010
-$174.46 M(+0.4%)
-$174.46 M(+0.6%)
Feb 2010
-
-$173.40 M(+1.4%)
Nov 2009
-
-$171.05 M(+4.3%)
Aug 2009
-
-$164.03 M(-5.6%)
May 2009
-$173.77 M(-4.3%)
-$173.77 M(+17.6%)
Feb 2009
-
-$147.70 M(-0.9%)
Nov 2008
-
-$149.00 M(-13.4%)
Aug 2008
-
-$172.04 M(-5.3%)
May 2008
-$181.59 M(+11.5%)
-$181.59 M(+0.6%)
Feb 2008
-
-$180.49 M(+4.4%)
Nov 2007
-
-$172.96 M(+7.3%)
Aug 2007
-
-$161.15 M(-1.1%)
May 2007
-$162.87 M(+9.0%)
-$162.87 M(+10.5%)
Feb 2007
-
-$147.38 M(-1.3%)
Nov 2006
-
-$149.31 M(-1.4%)
Aug 2006
-
-$151.37 M(+1.3%)
May 2006
-$149.45 M(+27.9%)
-$149.45 M(+5.2%)
Feb 2006
-
-$142.01 M(+5.3%)
Nov 2005
-
-$134.84 M(+5.1%)
Aug 2005
-
-$128.30 M(+9.8%)
May 2005
-$116.86 M(+30.7%)
-$116.86 M(+1.5%)
Feb 2005
-
-$115.12 M(-0.1%)
Nov 2004
-
-$115.19 M(+15.6%)
Aug 2004
-
-$99.66 M(+11.5%)
May 2004
-$89.40 M(+34.1%)
-$89.40 M(+4.8%)
Feb 2004
-
-$85.31 M(+4.8%)
Nov 2003
-
-$81.41 M(+13.1%)
Aug 2003
-
-$72.00 M(+8.0%)
May 2003
-$66.67 M(+36.1%)
-$66.67 M(+14.1%)
Feb 2003
-
-$58.44 M(+10.3%)
Nov 2002
-
-$52.98 M(+4.6%)
Aug 2002
-
-$50.66 M(+3.4%)
May 2002
-$48.99 M(+22.7%)
-$48.99 M(+10.4%)
Feb 2002
-
-$44.39 M(+2.5%)
Nov 2001
-
-$43.31 M(+4.2%)
Aug 2001
-
-$41.58 M(+4.2%)
May 2001
-$39.92 M(+29.6%)
-$39.92 M(+11.0%)
Feb 2001
-
-$35.96 M(+5.1%)
Nov 2000
-
-$34.20 M(+3.4%)
Aug 2000
-
-$33.07 M(+7.3%)
May 2000
-$30.81 M(+20.8%)
-$30.81 M(+9.1%)
Feb 2000
-
-$28.26 M(+5.9%)
Nov 1999
-
-$26.69 M(+4.4%)
Aug 1999
-
-$25.56 M(+0.2%)
May 1999
-$25.50 M(+12.9%)
-$25.50 M(+6.0%)
Feb 1999
-
-$24.06 M(+4.4%)
Nov 1998
-
-$23.05 M(+5.9%)
Aug 1998
-
-$21.77 M(-3.6%)
May 1998
-$22.59 M(+10.4%)
-$22.59 M(-0.5%)
Feb 1998
-
-$22.70 M(+4.9%)
Nov 1997
-
-$21.64 M(+3.0%)
Aug 1997
-
-$21.02 M
May 1997
-$20.46 M
-

FAQ

  • What is Aptose Biosciences annual retained earnings?
  • What is the all time high annual retained earnings for Aptose Biosciences?
  • What is Aptose Biosciences annual retained earnings year-on-year change?
  • What is Aptose Biosciences quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Aptose Biosciences?
  • What is Aptose Biosciences quarterly retained earnings year-on-year change?

What is Aptose Biosciences annual retained earnings?

The current annual retained earnings of APTO is -$515.54 M

What is the all time high annual retained earnings for Aptose Biosciences?

Aptose Biosciences all-time high annual retained earnings is -$20.46 M

What is Aptose Biosciences annual retained earnings year-on-year change?

Over the past year, APTO annual retained earnings has changed by -$51.21 M (-11.03%)

What is Aptose Biosciences quarterly retained earnings?

The current quarterly retained earnings of APTO is -$539.38 M

What is the all time high quarterly retained earnings for Aptose Biosciences?

Aptose Biosciences all-time high quarterly retained earnings is -$21.02 M

What is Aptose Biosciences quarterly retained earnings year-on-year change?

Over the past year, APTO quarterly retained earnings has changed by -$35.80 M (-7.11%)